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 Since 2010, Tuberculosis (TB) incidence in Shelby County, Tennessee has been 
steady with little fluctuation. During these years, however, TB incidence has been 
decreasing in Tennessee and the United States; except for 2015. The discrepancy between 
these trends may be due to sub-optimal TB prevention and/or treatment measures in 
Shelby County as compared to Tennessee and the United States. Therefore, it is pertinent 
to examine factors potentially associated with TB prevention among close contacts of TB 
cases to assess missed opportunities for prevention and eventually decrease the incidence 
of TB. Data from Shelby County TB cases during 2013-2015, and their contacts, are 
analyzed to describe the TB contacts magnitude and calculate number of contacts needed 
to receive preventive treatment to prevent one new case of TB. The study suggests that 
for every 100 people who go through preventive therapy, 1.5 individuals may be 
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One-third of the population in the world is infected with Tuberculosis (TB) 
bacteria. This infectious disease has been around for thousands of years and still causes 
turmoil in countless parts of the globe.
1
 TB ranked 9
th
 cause of death worldwide in 2015 
and is one of the world’s top infectious disease killers alongside human 
immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), diarrheal 
diseases, lower respiratory tract infections, and malaria.
2,3
 These five killers alone 
contribute to over one-eighth of the world’s death toll.
3
 TB, HIV/AIDS, and malaria 
collectively are responsible for almost 5 million deaths each year.
4
 In 2014, TB deaths 
surpassed the amount of HIV-related deaths worldwide with 1.5 million deaths compared 
to the 1.2 million deaths caused by HIV/AIDS.
5
 These numbers testify to the enormity of 
the burden of TB on public health globally. 
TB has been known as a poverty-related disease and the death toll is more 
prominent within low-income and low-middle-income compared to higher-income 
communities.
4,6
 However, even though TB is not a top ten killer within the upper-middle-
income and high-income economies, it can still be a disease problem in these societies. In 
2015, 10.4 million people were ill with TB and most were from low-income to middle-
income countries. However, on average, since 2000 the world TB incidence has 
decreased at 1.5% per year according to the World Health Organization (WHO).
7
 The 
elimination of TB is far in the future, but preventive measures and new treatment options 





Developed nations differ in regards to TB incidence and prevalence. The United 
States has a low TB incidence, but still experiences the affliction of the disease every 
year.
6
 Per the Centers for Disease Control and Prevention (CDC), the number of TB 
deaths reported throughout the United States has decreased since 1992 by 67% resulting 




Figure 1. Decreasing trend of TB incidence in the United States between 1992 to 
2015. Incidence data from the United States was obtained through the CDC.
8
 In 1992, the 
United States experienced the start of a 23-year decrease in incidence. This decrease was 
not apparent during the year 2015 when there was an increase of 151 cases from 2014.  
 
There are 4 states throughout the nation that account for 50.6% of the TB 
incidence in the United States: California, Florida, New York, and Texas. Within the rest 
of the 46 states, a majority have a case rate that is lower than the 3.0 per 100,000 
population case rate of the whole United States.
10
 However, there are counties throughout 
these states that represent a large portion of the TB cases reported in that state. One of 
























































































































United States TB Incidence 1992-2015 
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The effect of TB in the community of Shelby County, Tennessee continues to be 
significant from year to year (Figure 2). With a higher case rate in this region compared 
to the whole state of Tennessee and the United States, this endemic public health topic 
needs to be evaluated to comprehend what factors are making Shelby County more 
susceptible to TB.
8,11-21
 During the years 2006 to 2015, Shelby County had an average 
case rate of 6.9 cases per 100,000 population which was double the average case rate of 
Tennessee and the United States: 3.0 cases per 100,000 and 3.6 cases per 100,000 
respectively (Figure 3).
8,11-21
 Within the years 2006, 2008, 2012, 2014, and 2015 the TB 




Figure 2. Shelby County and Tennessee TB Incidence 2006-2015. A comparison of 
two populations, Shelby County, Tennessee and the whole state of Tennessee, were used 
in this 10-year trend. Data labels in the blue column are for Shelby County TB incidence, 
while the data in the orange column is the remainder of the Tennessee incidence 
excluding Shelby County. The count on the top of each column is the total TB incidence 
for the state of Tennessee corresponding to that year.
8,11-21
 







































Figure 3. Tuberculosis case rates per year for the United States, Tennessee, and 
Shelby County during 2006 to 2015. The case rates listed represent the United States, 
the state of Tennessee, and Shelby County, Tennessee.
8,11-21 
During this 10-year period, 
the drastic difference of Shelby County can be seen compared to the other two 
populations. 
 
From 2010 to 2015 TB rates in Shelby County stayed almost unchanged, while it 
was trending lower both in Tennessee and the United States (Figure 3). During these six 
years, the TB incidence experienced little fluctuation and ranged between 48 to 57 cases 
per year. The plateau may be due to prevention and/or treatment measures used in Shelby 
County that are less effective than those of Tennessee or the United States in general to 
combat TB. For these reasons, it is pertinent to examine factors that are potentially 
associated with TB prevention among TB cases’ contacts in Shelby County to understand 
what measures need to be done to decrease the incidence of TB in Shelby County. Data 
from Shelby County TB cases in the years 2013 to 2015, and their contacts, were 















2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
United States 4.6 4.4 4.2 3.8 3.6 3.4 3.2 3.0 3.0 3.0
Tennessee 4.6 3.8 4.5 3.2 3.0 2.4 2.5 2.2 2.3 2.0
Shelby County 11.7 7.9 9.7 7 5.2 5.2 6.1 5.1 5.5 5.2
TB Case Rates 2006-2015 
5 
 
analyzed to understand how many contacts are needed to go through preventive treatment 
to avert one new case of TB. This will allow for assessing missed opportunities for 
preventive therapy. 
The Study Objective 
The principal goal is to understand what actions need to be done to decrease TB 
incidence in Shelby County, Tennessee. The focus is on finding out how many past 
contacts have become sick with Tuberculosis disease (TBD) and how many received TB 
treatment of any kind. If they did not receive the appropriate treatment, we want to know 
if there was a missed opportunity to intervene. The following specific aims will be 
performed to address the study objective.  
1. Identify Shelby County TB cases between 2010 to 2015 from existing databases 
at the Shelby County Health Department (SCHD).  
2. Match the identified TB cases to a data set of over 943,000 TB, HIV, STD, and 
other test results to find the earliest test date for each case and calculate the 
fraction of cases that have previous test results in the SCHD system. 
3. Identify contacts of each TB case by abstracting the patient chart for each case in 
the TB Clinic indexed on each case’s unique ID. 
4. Identify the number of contacts who were diagnosed with TBD, TB Suspect, and 
Latent tuberculosis infection (LTBI). 
5. Calculate the proportion of contacts that were diagnosed with TBD, TB Suspect, 
or LTBI, who were offered the preventive treatment, and the proportions of 
contacts who accepted or rejected treatment. Additionally, calculate the 
proportion completed and did not complete the treatment among those who 
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accepted. The number of individuals who have previously been diagnosed as 
LTBI or TBD and gone through treatment will also be calculated. 
6. Perform data analysis using logistic regression to understand missed opportunities 
of prevention, the risk of transmission between cases and their contacts compared 
to their diagnosis, and what population is at most risk for transmission of TB 
considering age group, race, sex, and prior positive test. 
Research Question: How many TB contacts need to receive preventive therapy in order 
to prevent one case of TB? 
Hypothesis 1: Contacts specified as ‘high’ risk on their investigation sheet have a greater 
chance of developing TBD or becoming a TB suspect compared to individuals with a  
‘low’ or ‘moderate’ risk specified. 
Hypothesis 2: Individuals who have evidence of a prior positive TB test before they were 
named as a contact have a greater chance of developing TBD or becoming a TB Suspect 
compared to individuals without a prior positive test. 
Rationale 
This study aims to examine factors that may explain the current plateauing of TB 
cases in Shelby County despite the overall decrease in TB incidence in Tennessee and the 
United States. This research potentially will contribute greatly to improve the health of 
Memphis and Shelby County communities by providing important information to 
improve preventive treatment for TB. Information of TB case contacts can give us insight 
into how to prevent the spread of the disease. This research will benefit the populations in 
Shelby County that are affected by this deadly disease by providing valuable information 





Infectious diseases are found throughout history causing epidemics around the 
globe.
22
 It was believed that remarkable progress was made in the effort of eliminating 
these diseases and in the near future many developed countries would show positive 
results from using vaccinations and newer medications. However, this belief was short 
lived. In the 1980s, the world witnessed a pandemic of a new deadly disease AIDS.
22
 
This syndrome is caused by an emerging new viral pathogen, HIV infection that became 
more prominent during this time.
23
 Not only was there the issue of the new pandemic, but 
an additional infectious disease re-emerged during this period. That infectious disease 
was TB; a potentially deadly airborne transmissible disease. There was a resurgence of 
TB incidence between 1985 and 1992 due to increased numbers of HIV/TB co-infected 
individuals who activated TBD after they became immunosuppressed.
24
 
Emerging and re-emerging infectious diseases are a burden for many developing 
and industrialized countries worldwide. These infectious diseases challenge public health 
systems and there is need to develop effective policies and programs to control them.
25
 
With TB it is essential to understand the organism behind the infection, the different 
types of TB that can be contracted, and risk factors associated with the disease in hopes 
to decrease the incidence worldwide and one day eradicate this public health issue all 
together. 
Tuberculosis Organism 
TB has been around for centuries and is one of the oldest diseases recorded by 
mankind.
26
 Traces of TBD have been found in the spine of ancient skeletal remains. 
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However, it is unclear how the organism that causes TB came about. Speculation shows 
that the causal organism of TB may have appeared throughout water and soil then 
adapted to other hosts, such as animals and humans, throughout time.
27
  
A group of five mycobacteria is responsible for causing TB infection. This group 
of tubercle bacilli is known as the Mycobacterium tuberculosis complex (MTC).
22
 Even 
though all the MTC pathogens have been shown to cause infection throughout the human 
population, Mycobacterium tuberculosis (M. tuberculosis) primarily causes most cases of 
TB in the United States.
28
 This pathogen is transmitted through the air from person-to-
person. Transmission can occur through coughing, sneezing, singing, or speaking.
8
 
Another person can become infected after breathing in air that has been contaminated by 
small particles of this bacterium. Yet, this type of bacteria is considered moderately 
infectious. Out of the individuals who breathe in air contaminated by a case with M. 
tuberculosis, only 20% to 30% of them will become infected.
29
 After the bacteria is 
breathed in, the body activates defense mechanisms to regulate the infection. There are 




Tuberculosis Disease and Latent Tuberculosis Infection 
TB is found in two clinical forms; TBD and LTBI. TBD is the symptomatic, 
infectious form that affects an individual while LTBI is the presence of the dormant state 
of a bacterium in the body without causing symptoms due to the immune system being 
able to control it.
24
 When an individual becomes infected, TB starts out as LTBI.
22
 The 
issue here is that some individuals may never know they have this infection unless they 
get tested since it is asymptomatic. If LTBI goes untreated, there is a possibility of the 
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infection turning into the full-blown TBD.
22
 About 90% to 95% of people who become 
infected with LTBI, will never develop the infectious disease.
30
 However, the remaining 
5% to 10% will at some point in their life develop TBD. Depending on whether an 
individual has LTBI or TBD, there are separate treatment approaches to rid the body of 
the bacteria. 
Diagnosis and Treatment of Tuberculosis 
Symptoms associated with TBD are triggered due to the bacteria multiplication in 
the body. This results in an immune response throughout the host that may present 
symptomatically in the form of cough, fever, sweats, chills, chest pain, bloody sputum 
production, or weight loss.
22
 Presence of symptoms is just one of the ways TBD can be 
diagnosed clinically. Various laboratory tests such as Mantoux tuberculin skin test (TST), 
Interferon-Gamma Release Assays (IGRA), sputum culture, sputum smears, nucleic acid 
amplification (NAA), biopsies, and chest radiographs are also used to determine the 
difference between someone diagnosed as TBD or LTBI.
10,22 
During a typical TB 
screening, TST and IGRA blood tests are used to assess if an individual is infected with 
TB bacteria.
31
 However, other tests listed above, like chest radiographs or sputum 




Following the determination of an individual’s diagnosis, various treatment 
options are then put into play depending on what type of TB that person has. The Food 
and Drug Administration (FDA) oversees approval of drugs used for TB treatment. 
Currently, the FDA has permitted ten drugs that can be used to treat TBD. Out of these 





four agents include isoniazid (INH), ethambutol (EMB), rifampin (RIF), and 
pyrazinamide (PZA). A combination of these drugs will be given to an individual over a 
six to nine-month period. The type of treatment will be determined based on drug 
susceptibility, age, HIV status, and other criteria.
8
 TBD treatment differs from the 
treatment of LTBI. 
 LTBI is the asymptomatic form of M. tuberculosis infection. A person can go an 
extended amount of time without knowing they are infected with M. tuberculosis because 
laboratory tests are required to determine if an individual is infected. These tests will 
determine if the body has a response to a TB antigen.
22
 Like the diagnosis of TBD, LTBI 
is first identified by a TST or IGRA test. A positive TST or reactive IGRA test will show 
the infection of Mycobacterium tuberculosis in the body. Though, there is different 
criteria for what is considered a positive test depending on other risk factors that 















Table 1. Tuberculin Skin Testing.
8
 
Classification of the Tuberculin Skin Test Reaction 
An induration of 5 or more 
millimeters is considered 
positive in 
An induration of 10 or more 
millimeters is considered 
positive in 
>An induration of 15 or 
more millimeters is 
considered positive in any 
person, including persons 
with no known risk factors 
for TB. However, targeted 
skin testing programs 
should only be conducted 
among high-risk groups. 
HIV-infected persons Recent immigrants (< 5 
years) from high-prevalence 
countries 
 
A recent contact of a 
person with TB disease 
Injection drug users  
Persons with fibrotic 
changes on chest 
radiograph consistent with 
prior TB 









Persons who are 
immunosuppressed for 
other reasons (e.g., taking 
the equivalent of >15 
mg/day of prednisone for 1 
month or longer, taking 
TNF-a antagonists) 
Persons with clinical 
conditions that place them 
at high risk 
 
 Children < 4 years of age  
 Infants, children, and 
adolescents exposed to 




Tuberculosis (TB). Centers for Disease Control and Prevention Web site. 
https://www.cdc.gov/tb/default.htm Updated April 14, 2016. Accessed February 19, 
2017.  
 
Once determined that the patient has a positive test result and is diagnosed as 
LTBI, treatment options will be determined. LTBI treatment is designed to eliminate M. 
tuberculosis in the infected individual. Elimination of the bacterium will cure the disease 
12 
 
and the possibility of transmission and/or recurrence.
32
 There are four main preventive 
regimens that are approved by the CDC for LTBI: 6-month INH, 9-month INH, Isoniazid 
with Rifapentine (3HP), and RIF (Table 2).
8
 In the past, the favored treatment for LTBI 
was the INH for 9 months. However, comorbidities and health status take a role in 
choosing which type of preventive therapy is best suited for an individual (Table 2). The 
new preventive therapy regimen 3HP has become more popular within treatment options 
because it is shorter, easier to administer, and is less toxic to the liver than INH 
regimen.
33-35
 There is no evidence, however, as to which treatment is more effective. 
Sterling, et al. studied the effects of 3HP compared to INH and found 3HP was as 



































Drug Duration Interval Comments 
Isoniazid 
(INH) 
9 months Daily Preferred treatment for: 
   Persons living with HIV, Children aged 2-11, 
Pregnant Women (with pyridoxine/vitamin B6 
supplements) 
  Twice 
weekly* 
Preferred treatment for: 
   Pregnant Women  
(with pyridoxine/vitamin B6 supplements) 
Isoniazid 
(INH) 
6 months Daily  







3 months Once 
weekly* 
Treatment for: 
   Persons 12 years or older 
   Not recommended for persons who are: 
   Younger than 2 years old, Living with 
HIV/AIDS taking antiretroviral treatment, 
Presumed infected with INH or RIF-resistant M. 
tuberculosis, Women who are pregnant or 




4 months Daily  
*Use Directly Observed Therapy (DOT) 
 
Tuberculosis (TB). Centers for Disease Control and Prevention Web site. 
https://www.cdc.gov/tb/default.htm Updated April 14, 2016. Accessed February 19, 
2017. 
 
Recently in late 2015, the treatment regimen 3HP was introduced in Shelby 
County, Tennessee as an alternative to 9-month INH because 3HP is a combination of 
INH and Rifapentine (RPT). The half-life of RPT is 5 times longer than RIF which 





 Depending on how and when the medication will be administered will 
rely on which treatment is best suited for an individual. 
When regimens are taking weekly, DOT can be used. This strategy was invented 
as an adherence to monitor the patient taking their medication.
37
 DOT entails the 
individual being monitored while taking the medicine either in their home or at the clinic 
where they are being treated. This can be done by family members, public health 
professionals, or volunteers.
37 
If an individual is not using DOT, then the medication will 
be self-administered. Self-administration may become a problem with individuals who 
skip or decide to stop taking their medications. During instances of stopping therapy 
early, now more than ever the problem of antibiotic-resistance has come into play.
8,22
 
Antibiotic-resistance occurs when the is ineffective against the bacteria. This can make it 
difficult to properly treat the patient. Not only does this issue cost more money, 
depending on the type of antibiotic-resistance is encountered will determine what 
procedures need to be done accordingly.
38
 
At risk children, who are under the age of 5, may be put on what is called 
“Window Therapy” or “Window Prophylaxis.” This treatment option will be offered to 
young children who are close contacts to an active TB case.
28
 Even if the child does not 
test positive with a TST test, this preventive therapy may be utilized to prevent further 
spread of TBD. Once a child has been considered TB-free with a chest radiograph, they 
will go through window therapy until all three conditions are met for discontinuation: 
infant is 6 months or older, the second TST is negative, and the second TST has been 






 In the United States, two-thirds of the TB cases per year are individuals who are 
born in a country other than the United States; known as foreign-born. These individuals 
have a TB incidence that is around 13 times greater than the TB incidence among United 
States born (US-born) persons: 15.1 cases per 100,000 vs. 1.2 cases per 100,000, 
respectively.
24
 Foreign-born individuals typically develop TBD years after they arrived in 
the United States, which indicates a progression of LTBI to TBD in most cases.
24
 When 
LTBI goes untreated, it can progress to TBD. Reasons for this could be due to these 
individuals not being properly treated in their country of origin, which may also have 
high rates of TB transmission. 
China, Vietnam, India, the Philippines, and Mexico are the top countries where 
foreign-born individuals in the United States originate. These five countries account for 
45.2% of the population considered foreign-born in the United States. Similarly, these 




Risk Factors Associated with Developing Tuberculosis 
 There are multiple risk factors involved with an individual becoming infected 
with M. tuberculosis whether latently or actively. Environmental factors can lead to an 
increase risk of infection. Crowding in places such as barracks, shelters, and prisons can 
leave people vulnerable for contracting TB.
39
 In these tight quarters, it is easier for the 
bacteria to be spread through the air from person-to-person due to the proximity. 
Similarly, the duration of time spent with an active case of TB can increase the risk of 
16 
 
transmission to the contact. The severity of disease and cough frequency of the active TB 
case can contribute to risk of infection to a contact.
39
 
 Much of the LTBI individuals that progress to TBD do so within the first 2 years 
after infection. Though, the risk of infection becomes higher after the 5
th
 year of having 
an exposure to an active case.
29
 Additionally, HIV infection is identified as the highest 
effective biologic risk factor to develop TB. Individuals with HIV have an increased risk 
of TB reactivation.
22
 About 40% of individuals with HIV will progress to TBD several 






















Approval #4268 from the Institutional Review Board (IRB), at the University of 
Memphis, was obtained on June 15, 2016.  
Study Area and Sampling Plan 
 The study was performed at the Office of Epidemiology and the TB Clinic of the 
Shelby County Health Department (SCHD) in Memphis, Tennessee between May 2016 
to February 2017. Initial data was extracted from the National Electronic Disease 
Surveillance System (NEDSS) by the Office of Epidemiology to include TB cases from 
the years 2013, 2014, and 2015; including 149 cases total. These years were chosen due 
to the data being available compared to preceding years and they also have better contact 
investigation data included in each patient chart. Starting in 2013, documenting contact 
investigations became more advanced in Shelby County which allowed for improved data 
that are easily available. The 2013 to 2015 TB cases were matched to a dataset of over 
943,000 test results to find the earliest TB test on record at the SCHD for each case. For 
each case, the duration between the date the case was counted as diseased minus the first 
recorded TB test was calculated. This duration was categorized into three intervals: >30 
days, >60 days, and >90 days. The cases with >30 days were utilized to obtain their 
patient records in the TB Clinic. From the 149 TB cases of the years 2013 to 2015, 95 
(64%) made up the >30 days group. The patient records on each of the 95 cases were 
used to extract contact investigation information that included self-identified contacts or 
possible contacts for each case. Once contacts were obtained for each specified case, 
existing TBD/LTBI datasets in Microsoft Excel created by the SCHD were used to match 
18 
 
with the list of contacts acquired from the case patient files. In the end, 1,327 contacts 
were gathered from the patient files and used for analysis. 
Data Collection and Organization 
Preliminary data for the 149 TB cases from the years 2013 to 2015 were stored 
into one dataset by the Office of Epidemiology at the SCHD and included 281 variables. 
This “Case” dataset was used to match with another database of over 943,000 TB, HIV, 
and sexually transmitted disease (STD) test results from the years 2001-2015 and the 
fraction of cases with evidence of a prior TB test was calculated. The first name, last 
name, social security number, date of birth, and sex were used to match cases to names 
from the “Test” dataset. In some instances, race, ethnicity, and zip code were also used in 
the matching process to guarantee the accuracy. There were four main objectives in this 
matching process. First, identify the earliest TB test date on record for each TB case. 
Second, determine if the case was tested prior to the year of diagnoses. Third, identify the 
type of test that is the first on record for each case. Lastly, find the difference in days 
from the first TB test date on record to the date counted as diseased for each TB case. TB 
tests included TST, IGRA, and chest radiography which were the main ones observed. 
Evidence of a prior positive TB test was pertinent to this investigation because it may 
have meant there was a former opportunity to intervene with that individual before they 
became a case. It also gave us insight to whether they were previously diagnosed with 
TBD, TB suspect, or LTBI.  
In the original Case dataset that was extracted from the NEDSS, TB test dates 
were recorded. The TB test dates specified in the Case dataset were matched with the 
ones in the Test dataset. The reason for matching was to make sure the dates were the 
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same and to see if the case had been in the SCHD system previously for another type of 
test. Also, it was relevant to understand if the earliest test date for that individual was due 
to something other than TB: HIV or STD. After matching the individuals from the Case 
dataset to tests in the Test dataset, 144 of the 149 were found with a TB test. The 5 
remaining TB case’s name, date of birth, and social security numbers could not be 
matched in the Test dataset. However, these 5 had test dates specified in the Case dataset 
and those were used. TB tests including TST, IGRA, NAA, culture, smear, and chest 
radiography were specified in the case dataset. 
After the two datasets were matched, a new Microsoft Excel spreadsheet was 
created using a copy of the original to include material from each dataset regarding TB 
cases from the years 2013-2015. The new dataset included variables that allowed 
examination if any case was tested before they were diagnosed with TB, diagnosis date, 
first test on record at SCHD, and first TB test date. The interval between the date the case 
was counted as diseased and the first recorded test date was calculated. In this research, 
date counted was used because that is the day the CDC and the SCHD reports yearly for 
TB cases and it is used as the diagnosed date. 
The cases with the calculated intervals of >30 days were included in this study 
due to time constraints. The one-month gap between the two dates is noteworthy to 
consider the potential for opportunity to intervene. The individuals who had a difference 
between the count date and test date of greater than 30 days were included in the final 
analysis, which included around 64% of the 2013-2015 TB case list; 95 cases. Dates 
calculated ranged from -55 to 7,750 days. Negative numbers were not included with the 
variables because the presence of a negative variable meant that the case was counted as 
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diseased prior to the first test date on record at the SCHD. Twelve of the 54 cases (22%) 
not included in the study had a negative difference or no difference. Due to the study 
focusing on missed opportunities to prevent, these cases would not have given any 
indication towards the hypothesis because they did not have a preventive opportunity. 
The remaining 42 of the 54 cases not included in the study, had a difference of 1-30 days 
from the date of testing to the date of diagnosis and were not included due to time 
constraints. 
Patient charts for the 95 TB cases that were included in the study were acquired 
through the TB Clinic at the SCHD. Using the case’s state ID number, local patient ID 
number, first name, last name, date of birth, and genotype if given, members of the TB 
Clinic pulled charts to allow for data abstraction. Contacts in the patient charts were 
acquired using a chart abstraction tool that was developed for this study (Figure 4). The 
charts were reviewed to gather information on all contacts named through the contact 
investigation upon diagnosis of the case. Contacts in patient charts included the ones that 
were self-identified by the case and ones that were possible contacts named by the 
school, prison, shelter, or institution to which some patients belonged. For each contact, 
the following information was abstracted: first name, last name, demographics, date of 
birth, social security number, relation to case, address, phone number, date listed as 
contact, first exposure date, last exposure date, test type, test date, test result, evidence of 
prior positive, risk of transmission, diagnosis, diagnosis date, previous diagnosis date, 
whether LTBI treatment was offered, type of LTBI treatment, LTBI treatment initiation 
date, and LTBI treatment end date. If the contact was later diagnosed with TBD, 
additional information about type of TB treatment, TB type, TB treatment initiation date, 
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TB treatment end date, culture test result, smear test result, genotype, and whether the 
contact was fully evaluated was collected. Out of the 95 cases, 16 did not have contacts 
listed within their patient charts. Many of the 16 cases were diagnosed with 
extrapulmonary TB and therefore were not contagious and contact investigation was not 
needed. The information about the contacts was used to create a new “Contacts” dataset 
and included 1,325 contacts. 
Next, the Contacts dataset was compared to a “LTBI” dataset from the TB Clinic 
in the SCHD made up of patients who come on Wednesdays to their clinic hours that are 
homeless or have been named as contacts in previous investigations. The Wednesday 
clinic hours were designated as a TB and HIV testing facility to the homeless population 
in Shelby County. These tests are free. Among the patients that came to Wednesday 
clinic, those who were diagnosed as LTBI were identified and matched with the TB 
case’s state ID number and county ID number from the Contacts dataset. If state- or 
patient ID numbers matched between the two datasets, then the contacts listed in the 
Wednesday TB Clinic dataset were added to my Contact dataset. To prevent duplication, 
the first name, last name, demographics, social security number, address, and phone 
number of each contact were matched within the two datasets. Much of the contacts listed 
were already on the contacts dataset and were not needed to be added again. During the 
matching process, if updated information regarding tests or diagnosis of the contact were 
found, the Contact dataset was updated. This action ensured all recorded contacts of each 
case are identified, linked to that case, and included all information available about the 





 The 95 cases that were used in the study were compared to the total 149 cases in 
the original SCHD dataset to see if there were any differences in distribution of age 
group, sex, race, and ethnicity between the two groups. The contacts were also compared 
with their cases in terms of age, sex, race, and ethnicity. Frequencies were calculated 
using SAS (SAS Institute, Cary, NC) to determine the demographic makeup of the 2013-
2015 TB cases and contacts. 
Next, the number of contacts to each case, the number of cases linked to each 
contact, the number of cases who shared contacts, and the number of cases named as a 
contact to another case were calculated. The percent of contacts that newly developed or 
were previously diagnosed as TBD, TB Suspect, or LTBI were also determined. Of each 
of these three contact categories, the proportion offered preventive therapy and the 
proportion accepted the offer of preventive therapy were calculated. Of those who 
accepted the preventive therapy, the proportions who completed, did not complete, or 
stopped preventive therapy were determined. The number of contacts who had a previous 
positive TST or IGRA test prior to being named a contact was also identified. 
The “relationship” variable, listed on the contact investigation sheets, showed the 
relationship between the case and their contact. Relationships were classified into 8 broad 
groups; casual, congregate setting, extended family, friend, healthcare setting, immediate 
family, other household contacts, and school/work setting. The “risk” variable specified 
the risk of transmission to the contact. The different risk categories, low, moderate, and 
high, were assessed in the relationship groups that had the highest frequency. In the risk 
variable, frequencies were assessed between the three categories. Logistic regression was 
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used to determine the association between risk and the diagnosis of TBD or TB Suspect. 
Logistic regression was used to examine the adjusted associations of age group, race, and 
sex with susceptibility to TB. Additionally, logistic regression was utilized to assess the 
relationship between prior positive TB test and the diagnosis of TBD or TB Suspect.  
All statistical analyses were performed using SAS statistical software (SAS 






















The total number of TB cases in Shelby County, Tennessee between the years 
2013 to 2015 was 149. Roughly 64% of the cases, 95, were utilized to gather contact 
information from their patient charts in the TB Clinic. Distributions of sex, age group, 
race, and ethnicity were compared between the two case cohorts (Table 3).  
Table 3. Case Distribution Comparison. The overall cohort of 149 cases was compared to 
the study cohort of 95 cases to understand the distribution between four variables; sex, 








Sex Frequency (Percent) 
     Male 96 (64%) 56 (59%) 
     Female 53 (36%) 39 (41%) 
Age Group   
     0-14 21 (14%) 19 (20%) 
     15-24 20 (13%) 11 (12%) 
     25-44 50 (34%) 28 (29%) 
     45-64 43 (29%) 27 (28%) 
     65+ 15 (10%) 10 (11%) 
Race   
     Asian 10 (7%) 6 (6%) 
     Black or African American 107 (72%) 68 (72%) 
     White 32 (21%) 21 (22%) 
Ethnicity   
     Hispanic or Latino 23 (15%) 14 (15%) 
     Not Hispanic or Latino 126 (85%) 81 (85%) 
 
The two cohorts had similar demographic characteristics. However, there were 
small variations in some categories. The majority were males in both cohorts compared 
(64% of the overall cohort and 59% of the study cohort). The median ages were 39 and 
38 in the overall and the study cohorts, respectively. Racial distributions were similar 
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with the majority being Black or African American (72% in both cohorts). Lastly, 
ethnicity was similar with 85% of the cases not Hispanic or Latino. 
Eleven percent of the 95 cases tested positive for HIV and 12% stated 
homelessness status within the year before being diagnosed. About 69 cases (73%) were 
born in the United States. The proportion of US-born TB cases in Shelby County is 
different from that in the whole United States. A majority of TB cases in the United 
States are foreign-born. 
 Around 48% of the individuals were diagnosed with pulmonary TB, while 35% 
were diagnosed with extra pulmonary TB and 17% diagnosed with both. The 48% 
diagnosed with pulmonary TB are those who are able to transmit the disease to others. 
Most cases were verified by clinical case definition (54%) or positive culture (38%). The 
other 8% were verified by a positive NAA or verified by a provider’s diagnosis. The 
reasons for TB evaluation were TB symptoms (39%), abnormal chest radiograph (26%), 
case-contact investigations (20%), and incidental lab results (11%). The remaining 4% 
were diagnosed through employment or during an immigration medical exam.  
Contact Cohort 
After chart abstraction of the 95 TB cases and matching to the Wednesday TB 
Clinic dataset, there were a total of 1,327 contacts to be evaluated. Sixteen of the 95 cases 
did not have contact investigation charts in their files. This could be because the case was 
diagnosed with extrapulmonary TB, the case passed away prior to investigation, or the 
case did not have any contacts. To assess the similarities of the cases to their contacts, 
distributions of age, sex, race, and ethnicity were obtained and compared (Table 4). 
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However, not every contact gave their demographic information to the contact 
investigation (Table 4). 
The number of contacts to each case, the number of cases linked to each contact, 
the number of cases who shared contacts, and the number of cases named as a contact to 
another case were identified. On average there were around 14 contacts to 1 of the 95 
cases. Excluding the 16 cases without contacts, changed the average to 17 contacts per 1 
of the 79 cases. There were 88 individuals who were named as a contact to multiple cases 
and 10 of the 88 (11%) were named in three or more contact investigations. Of the 79 
cases, 19 had similar contacts between at least one of the other cases and 7 of the 19 
(34%) cases shared contacts with at least two other cases. Lastly, 14 of the 95 cases were 
named as a contact within another case’s contact investigation. In all 14 of the cases, 
























Table 4. Study Cohort and Contact Cohort Comparison. The study cohort of 95 cases 
was compared to the contacts collected. The total contacts collected do not equal the 
amount of contacts (1,327) due to a number of individuals not specifying demographics 
during the contact investigation. 
 





Sex Frequency (Percent) 
     Male 56 (59%) 508 (49%) 
     Female 39 (41%) 538 (51%) 
Age Group   
      0-14 19 (20%) 206 (19%) 
     15-24 11 (12%) 248 (23%) 
     25-44 28 (29%) 317 (29%) 
     45-64 27 (28%) 267 (24%) 
     65+ 10 (11%) 53 (5%) 
Race   
     Asian 6 (6%) 34 (4%) 
     Black or African American 68 (72%) 722 (76%) 
Race   
     Native Hawaiian or Other Pacific Islander . 7 (0.7%) 
     White 21 (22%) 186 (20%) 
Ethnicity   
     Hispanic or Latino 14 (15%) 135 (15%) 
     Not Hispanic or Latino 81 (85%) 788 (85%) 
 
Three comparisons were made to better understand the differences between the 
cases and their contacts. Frequencies of sex, age group, race, and ethnicity were 
calculated. Comparisons were made in the study cohort to the contact cohort collected in 
the study. The distribution of sex was different (59% were male in case cohort vs. 49% 
were male in the case contacts collected). The age distribution differed slightly between 
the two cohorts. The median age in the contact cohort was 30. The majority in both 
cohorts were Black or African American at 76% vs. 72% in contacts and case cohorts. 
Previous Positive and Risk of Transmission 
 Throughout the contact investigation sheets, an area was specified for comments 
by the provider, nurse, or investigator. Included within these comments were the reasons 
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why individuals did not get fully evaluated and if they have been tested positive for TB 
prior to the meeting. Sixty individuals, accounting for 5% of the contacts with the 
previous positive variable, stated they have tested positive for TB prior to the 
investigation. Out of the 60 individuals, 4 were diagnosed as TBD or TB suspect and 15 
were diagnosed LTBI.  
Another important variable is the risk of transmission specified on the contact 
investigation sheets as high, moderate, or low. A majority of the contacts were recorded 
either at a moderate or high risk of transmission from the active TB case; 531 (49%) and 
473 (43%) contacts, respectively. Only 87 individuals were considered at low risk of 
transmission that accounted for 8% of the collected contacts. 
Relationship of Contact to Case 
 The relationship of each contact to their associated case was specified in the 
contact investigation sheets and included for analysis (Figure 5). Establishing the 
relationship between cases and their contact will allow for understanding the mode of 





Figure 5. Relationship of Contact to TB Case. Relationships listed for individuals were 
put into 8 categories. Fifty-two contacts did not have specified relationships on their 
contact investigation sheet and therefore are missing from the percentages. 
 
The largest group of contacts was in the “congregate setting” category (372, 
29%). These individuals included people that the case came in contact with at a shelter or 
prison. Whether it was the case’s arresting officer, dorm mate, staff at the prison/shelter, 
resident at the shelter, or inmate, these were all included within the congregate or large 
group setting category. The next largest group was the “school/work setting” (326, 26%). 
Owners, managers, supervisors, coworkers, bus drivers, classmates, teachers, and school 
employees were included in this category.  
 Family was classified into two categories; extended and immediate family. 
“Extended family” included aunts, uncles, cousins, in-laws, godparents, unspecified 
family members, grandparents, grandchildren, nephews, nieces, and stepparents. While 
the “immediate family” category included parents, siblings, and children. Extended 
family accounted for 17% of the contacts while immediate family accounted for 13%. 




























regular basis were included within the “other household contacts” group. These 
individuals were significant others, spouses, significant others to family members, 
caregivers, and roommates. Other household contacts accounted for 5% of the contacts. 
Close friends were put in their own category, because they may be seen in multiple 
setting throughout each case; school, work, home, etc. Individuals included in the 
“friend” category were only ones who were close to the actual case, and not friends of 
family members. This group accounted for another 3% of the contacts’ relationships 
collected. 
There were 45 individuals accounting for 3% of the contacts who were in the 
casual category. Lastly, the “health-care setting” was used as a category. These 
individuals included employees of the hospital/clinic, funeral home workers, doctors, 
specialists, and roommates while in the hospital. There were 45 health-care setting 
contacts (3%). 
After establishing the relationships between the case and their contacts, risk of 
transmission was included within the investigation alongside the relationship variable. 
Since congregate setting (Figure 6) and school/work setting (Figure 7) were the largest 
categories for the relationships, analysis was performed to see the distribution of the risk 




Figure 6. Risk of Contacts in Congregate Setting. Individuals listed as contacts within 
the shelter or prison setting and the distribution of transmission risk. 
 
Within the congregate setting, a majority of individuals (91%) were considered 
moderate or high risk of TB transmission on their contact investigation sheet (Figure 6). 
This gave only 9% of individuals a low chance of transmission between the active case 
and the specified contact. After breaking up the moderate and high categories, moderate 
has a higher frequency at 54% than high (36%). However, individuals within the high or 












Figure 7. Risk of Contacts in School/Work Setting. Individuals listed as contacts 
within the school or work setting and the distribution of transmission risk. 
 
Individuals in the school/work setting had different risk of transmission 
distribution than that of the congregate setting (Figure 7). Only 4% had a low risk of 
transmission, while 96% had a moderate or high risk of transmission. Unlike the 
congregate setting, the moderate and high risk had a closer to even distribution, but the 
high risk category was more (49%). The moderate risk accounted for 47% of the 
moderate and high risk. 
Diagnosis of Contacts 
 Once the risk of transmission was understood, it was pertinent to find individuals 
who developed TBD, LTBI, or became a TB Suspect. Diagnosis was put into four 











Figure 8. Diagnosis of Contacts to Selected 2013-2015 TB Cases. Diagnosis of the 
1,327 contacts after the contact investigation. Four categories of diagnosis were 
discovered; TBD or TB Suspect, LTBI, Previous Diagnosis, and No TB Diagnosis. 
 
 Individuals with previous diagnosis (2%) included previous TBD, previous TB 
suspect, and previous LTBI. Individuals with no TB diagnosis accounted for 86% of the 
contacts. Individuals who had a missing diagnosis variable on their contact sheet were 
considered “not specified” and accounted for 37% of the ones considered “no TB 
diagnosis.” Among all 1,327 contacts assessed during this study, 21 were diagnosed with 
TBD and another 4 diagnosed as TB Suspect; accounting for 2% of the contacts. Sixteen 
of the 25 (64%) TBD or TB Suspect diagnosed individuals were at high risk of 
transmission, 5 of the 25 (20%) were at moderate risk of transmission, 1 of the 25 (4%) 
was at low risk of transmission, and 3 of the 25 (12%) did not have the risk of 
transmission specified. Of the 25 diagnosed with TBD or TB suspect, 13 had their type of 
TB ascertained during their contact investigation. Sixty-two percent were diagnosed as 
pulmonary TB from the individuals with the type of TB specified in the contact 
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of TB in their body. Age of 0-14 years, male sex, and black or African American race 
were risk factors for TBD in the contacts. 
There were 129 contacts diagnosed as LTBI during the study. Within the 1,327 
contacts, 39 individuals have been previously treated for LTBI prior to the contact 
investigation. Excluding the individuals who have previously been treated, there were 
180 offered LTBI preventive therapy treatment (Figure 9). The 10% of the contacts 
diagnosed as LTBI, as well as other contacts at risk (young children, immigrants, ones 
with medical conditions associated with weakening the immune system, individuals 
recently infected with TB, etc.), were offered LTBI treatment.
8
 Of the 180 individuals 
offered therapy, 63% completed it. Even though this number is over half, it needs to be 
higher. Individuals who did not complete their treatment or refused to receive treatment 
constituted 21% and 6%, respectively, of the 180 who were offered preventive therapy. 
Ten percent of the individuals had missing data on completion of preventive therapy. 
 
Figure 9. LTBI Treatment Completion of 180 Contacts Offered Treatment. 










LTBI Treatment Completion of 180 







 The next step to understand treatment delivery was to determine which group was 
more likely to be offered treatment. As one might expect, those with high or moderate 
risk were offered LTBI treatment more often. Eighty-one of the 473 individuals with a 
high risk of transmission (17%), 69 of the 531 individuals with moderate risk of 
transmission (13%), and 11 of the 87 individuals with low risk of transmission (13%) 
were offered preventive therapy. There were 19 of the 180 individuals who were offered 
treatment that did not have a risk of transmission stated in their contact investigation 
sheet. 
 Only 103 (57%) of the 180 contacts offered preventive therapy had the type of 
LTBI treatment identified on their contact sheet. Among the ones identified, 58% went 
through INH, 37% went through window therapy, 3% was given 3HP, and the remaining 
2% either took RIF or switched from INH to RIF. An analysis of interest was looking 
into each treatment regimen and seeing which one had the highest completion rate (Table 
5).  
Table 5. LTBI Treatment Regimen and Treatment Completion Status. 3HP, INH, RIF or 
INH/RIF, and Window Therapy were the four types of treatment that were specified 
during the contact investigation. No individuals that rejected treatment had the type of 
LTBI treatment specified and were not included within the table. 
 
LTBI Treatment Regimen and Treatment Completion Status 
Completion 
Status 
LTBI Treatment Regimen 
 3HP INH RIF or INH/RIF Window 
Therapy 
Total 
Completed 2 28 0 35 65 
Not Completed 0 20 1 1 22 
Not Specified 1 12 1 2 16 




3HP had a completion of 67%, INH had a completion of 47%, RIF or INH/RIF 
had a completion rate of 0%, and window therapy had a completion of 92%. The window 
therapy category included INH, window therapy and other window therapy that did not 
have a specified regimen; however, it was most likely INH due to the recommended 
treatment regimens specified by the CDC.
8
 This category was separated to show 
individuals that may have not been diagnosed LTBI, but went through therapy due to 
their age or other risk factors. 
Bivariate and Multivariable Analyses 
A crude analysis of risk variable and diagnosis was evaluated using logistic 
regression. Risk was considered the explanatory variable while diagnosis as the outcome. 
The outcome variable was the log odds of an individual being diagnosed with TBD or TB 
Suspect. Moderate was used as the reference level because it was the most commonly 
reported risk category.
41
 Moreover, comparison between the moderate risk factors and 
high risk factors was desired because these are the individuals who may have 
comorbidities. Individuals with high risk have factors that are significant to transmission; 
contact with TB infected individual, elder population, HIV, or transmission through an 
institute. Ones considered at a moderate risk of transmission were malnourished 
individuals, smokers, diabetics, and the poor.
42
 The test found a significant association 
with high risk developing TBD or TB Suspect. The odds of developing TBD or being a 
TB Suspect and being at high risk was 3.7 (95% CI: 1.3, 10.1) times the odds of an 
individual at a moderate risk (Table 6). 
An adjusted analysis was performed with the outcome of TBD or TB Suspect 
diagnosis and race, age group, and sex as explanatory variables. During the procedure, 
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possible quasi-complete separation was noted in the log showing that some variables did 
not converge. Multiple attempts were made to fix this separation by changing the 
iterations; however, the estimates did not converge. Reference levels were specified in 
the categories of each variable that had the greatest frequency.
41
 Additionally, the age 
group of 25-44 was used as the reference level because this group has shown an increase 
in TB compared to other groups. The higher TB prevalence may be due to being the 
primary group affected by HIV/AIDS.
7,28,43
 The 25-44 age group, Black or African 
American, and Female were the reference in each variable. The model found, individuals 
0-14 years of age have an 8.2 times the odds of developing TBD or being a TB Suspect 
(95% CI: 1.8, 37.5) compared to those 25-44 years old, after holding all other variables 
constant (Table 6). 
 The final logistic model tested whether prior TB test status was associated with 
the diagnosis of TBD and TB Suspect. No presence of prior positive TB test was used as 
the reference.
41
 Those with a positive prior TB test have 3.8 (95% CI: 1.271, 11.622) 
times the odds of developing TBD or being TB Suspect compared to an individual who 
does not have a prior positive TB test (Table 6). 
Table 6. Significant Findings through Bivariate and Multivariable Analyses. Through 
analysis, odds ratio (OR), confidence interval (CI), and the p-value were obtained within 
each regression. 
 
Significant Findings through Bivariate and Multivariable Analyses 
 OR 95% CI P-value 
Risk    
High vs. Moderate 3.682 (1.339, 10.129) 0.0116 
Age Group    
0-14 vs. 25-44 8.248 (1.812, 37.535) 0.0063 
Prior Positive and Diagnosis    




Stratified Analysis of Tuberculosis Diagnosis 
According to the study, 2% of individuals were diagnosed as TBD or TB suspect; 
with 48% of them being diagnosed as pulmonary TBD. Some of these individuals were 
named as contacts within multiple investigations. Due to this, the TBD and TB suspect 
diagnosed individuals were de-duplicated to answer the research question in this study. 
The de-duplication left 20 of the 25 individuals; accounting for 1.5% of the contact 
cohort. This suggests that for every 100 people who go through preventive therapy, 1.5 
individuals may be prevented from developing TB. Likewise, for every 1,000 people who 
go through LTBI preventive therapy, 15 cases of TB may be prevented. 
 Stratified sampling was done for the individuals diagnosed as TBD or TB suspect 
to see what the preventive opportunity is based on the groups with the highest odds ratio 
in logistic regression. Three different strata were considered for individuals diagnosed 
TBD or TB suspect; adult versus child, foreign versus US-born, and low versus high risk 
of transmission. Pediatric cases are considered 14 years of age and below while adults are 
15 years of age and higher. Forty-five percent of the de-duplicated TB cases were 
pediatric, 45% were adults, and 10% did not specify age. The stratified preventive 
opportunity for age did not differ between the two groups (0.68 per 100 people or 6.8 per 
1,000 people). With risk, 5% of the de-duplicated TB cases were at low risk, 20% were at 
moderate risk, 60% were at high risk, and 15% did not have risk of transmission defined. 
The preventive opportunity for individuals at a low risk of transmission is 0.08 per 100 
people (0.8 per 1,000 people) who go through preventive therapy, while individuals at a 
high risk of transmission are 0.9 per 100 people (9 per 1,000 people) who go through 
preventive therapy. Lastly, there are a higher percentage of US-born individuals with TB 
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in Shelby County, Tennessee compared to the United States. Of the de-duplicated TB 
cases, 70% were US-born, 5% were foreign-born, and 25% did not have country of birth 
specified in their contact investigation sheet. The preventive opportunity for US-born is 
1.1 per 100 persons, or 11 per 1,000 people, who go through preventive therapy. 
Individuals who are foreign-born in Shelby County have a 0.08 per 100 people (0.8 per 
1,000 people) preventive opportunity of not developing TB if treated properly. The two 
countries of origin figures may not be generalized to the United States population due to 




















 This study focuses on the importance of infectious disease surveillance and 
control in regards to TB. This potentially deadly, airborne disease is endemic to a 
multitude of countries and is also found within the United States.
8 
With rates that are 
slowly declining, TB may be a candidate for eradication in the future.
22
 In Shelby 
County, Tennessee between 2010 and 2015 the incidence of TB has been at a plateau 
with little variance from year to year.
11-21
 
Individuals who had evidence of a prior positive TB test had an approximately 
four-fold chance of developing TBD or becoming a TB suspect compared to the 
individuals who did not have a prior positive TB test. These individuals needed to be 
analyzed to understand why the diagnosis was missed that they developed TBD after the 
positive test. These individuals could be amongst the 5% to 10% that will develop TBD 
from LTBI at some point in life.
30
 However, they may have been unaware that they were 
infected with TB in the first place.
22
 Missed diagnosis of LTBI or TBD can be 
detrimental to not only that individual, but to ones they come in contact with on a regular 
basis. 
Individuals within the relationship groups of congregate setting and school/work 
setting had the highest proportion. Individuals that the active case came in contact with 
would be anyone at prison, shelter, school, or work. Another 32% of the individuals in 
the study cohort were between 0-24 years of age. Indicating, a good portion of these 
individuals may be in some type of schooling system, which may expose students to TB, 
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especially given that the young age group was shown to be at a much increased risk of 
the disease middle-aged groups. 
Not only is it important for surveillance to be a part of elimination of TB, control 
methods are needed to sustain past endeavors. TB control efforts include vaccination and 
treatment options. In countries where TB is at high prevalence, the Bacillus Calmette–
Guérin (BCG) vaccination has been used to control the spread of TB.
22
 In these same 
countries, or ones that do not use the BCG vaccine (United States), preventive therapy is 
offered to individuals who may have a higher risk of transmission.
8
 An important factor 
is making sure the patient is truly taking their medication and not stopping it too early.
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If the treatment is completely finished then prevention of TB should occur. 
Limitations 
Time constraints were a major limitation to this study. We were able to abstract 
data of only 64% of TB cases from 2013 to 2015 to find their contacts, which may have 
introduced selection bias to the study. The second limitation is the small size of cases. 
This can be avoided in the future by collecting data from more years. 
 The third limitation to this study is extracting data from multiple sources to form 
one contact dataset from the 2013 to 2015 TB cases. If matched properly, this restraint 
should not be an issue. However, errors from multiple merging and matching different 
datasets can occur and affect the data quality. 
Recommendations 
 In future research, these limitations should be addressed. By accounting for the 
limitations, additional cases can be used to acquire contacts for the analysis and a 
superior method of data collection from one source can be utilized. Having an increased 
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number of contacts will increase the accuracy that the data is representing the whole TB 
community of Shelby County, Tennessee. 
 Surveillance and data collection procedures need to be improved as well in order 
to decrease TB and understand the distribution of cases in Shelby County. Increasing 
surveillance efforts will enhance the ability to find active TB cases. Performing contact 
investigations for each contact within each case of reported TB will allow locating 
individuals who may soon develop TBD from LTBI. Contact investigations also assist 
with diagnosis of LTBI since it is asymptomatic and an individual could go years without 
knowing they are infected. Data collection from these contact investigations need to be 
thorough. In-depth investigations may decrease the amount of missing variables and 
ultimately help in analysis. 
 The major recommendation from this study is to increase the amount of 
individuals who go through preventive therapy. It is recommended that more individuals 
be offered preventive therapy to decrease the incidence of LTBI that may eventually 
advance to TBD. It is suggested that every 100 people put through preventive therapy for 
LTBI may prevent up to 1.5 cases of TB. If the proposed finding is addressed and more 
individuals go through preventive therapy, TB numbers will be down in Shelby County. 
Ultimately, it will be decreasing the mode of transmission between active cases to 
contacts. It would also benefit public health programs by treating individuals who are 
specified as high risk of transmission.   
 Additionally, increasing the amount of DOT may assist with individuals 
completing therapy. When a patient is being observed, they are more likely to complete 
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the therapy out of courtesy. If allowed to take the medication on their own, there’s 


























Understanding what makes Shelby County, different than the rest of the United 
States is important. A majority of the TB population of Shelby County is US-born, which 
naturally is not the case throughout the nation that shows a vast number of foreign-born 
diagnosed individuals.
22
 This may lead to the necessity of improvement of contact 
investigations and standardizing TB surveillance data collection. 
One way to address this public health issue and improve TB prevention and 
treatment in Shelby County is to identify contacts of new confirmed cases and provide 
timely preventive treatment to prevent them from contracting the disease. Through 
contact investigations, missed opportunities for prevention can be found leading to the 
result of a multitude of cases. Additionally, preventive therapy is needed to be offered to 
more people in order to prevent persons with LTBI developing to TBD cases. The 
recommendations found from this study should be taken to make administration of 
preventive therapy regimens easier, more precise, and ultimately effective. Constant 
surveillance and control efforts need to be sustained to decrease the incidence or 
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Chart Abstraction Tool 
 
Figure 4. Chart Abstraction Tool. This tool was created in particular for this study 
through Microsoft Word. Each sheet allowed for 1 case and 4 contacts to be extracted. 
This tool was essential in data abstraction and cut down on time from acquring data in the 






















The University of Memphis Institutional Review Board, FWA00006815, has reviewed 
and approved your submission in accordance with all applicable statuses and regulations 
as well as ethical principles. 
 
PI NAME: Leah Reish 
CO-PI:  
PROJECT TITLE: Prevention of Tuberculosis Disease in Previously Infected Individuals 
of Shelby County, Tennessee 
FACULTY ADVISOR NAME (if applicable): Fawaz Mzayek 
IRB ID: #4268 
APPROVAL DATE: 6/15/2016 
EXPIRATION DATE:  
LEVEL OF REVIEW: Exempt 
 
Please Note: Modifications do not extend the expiration of the original approval 
 
Approval of this project is given with the following obligations: 
 
1. If this IRB approval has an expiration date, an approved renewal must be in effect to 
continue the project prior to that date. If approval is not obtained, the human consent 
form(s) and recruiting material(s) are no longer valid and any research activities 
involving human subjects must stop.  
 
2. When the project is finished or terminated, a completion form must be completed and 
sent to the board. 
 
3. No change may be made in the approved protocol without prior board approval, 
whether the approved protocol was reviewed at the Exempt, Exedited or Full Board level. 
 
4. Exempt approval are considered to have no expiration date and no further review is 
necessary unless the protocol needs modification. 
 
Note: Review outcomes will be communicated to the email address on file. This email 
should be considered an official communication from the UM IRB.  
